Oxybutynin Chloride NDC 63187-749

NDC codes

FDA NDC Directory

Product NDC (as listed)63187-749Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63187-0749Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
63187-749-30	63187074930	30 TABLET in 1 BOTTLE (63187-749-30)Marketed from Oct 3, 2016
63187-749-60	63187074960	60 TABLET in 1 BOTTLE (63187-749-60)Marketed from Oct 3, 2016
63187-749-90	63187074990	90 TABLET in 1 BOTTLE (63187-749-90)Marketed from Oct 3, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxybutynin Chloride
Generic name (nonproprietary): oxybutynin chloride
Active ingredients: Oxybutynin chloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 071655
Marketing start: Sep 30, 1990
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 63187-749_086f1e11-bff2-4f7b-9591-2ba9e1fdf217SPL ID 086f1e11-bff2-4f7b-9591-2ba9e1fdf217SPL set ID e3f0c249-8085-4979-823a-820e233a284fRxCUI 863664UNII L9F3D9RENQUPC 0363187749309
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187074930 followed by a unit qualifier and the quantity

Package 63187-0749-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Oxybutynin Chloride Tablets USP are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 071655

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 071655
Product	Strength	Form · route	Labeler	Product NDC
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	Bryant Ranch Prepack	71335-0519
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	direct rx	72189-130
Oxybutynin Chloride	Oxybutynin chloride 5 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	50111-456